Moderna, Inc. recently announced significant advancements in its mRNA medicine portfolio, spanning respiratory diseases, latent viruses, oncology, and rare diseases. This article provides a comprehensive overview of these updates, highlighting key clinical trial results and future development plans, offering valuable insights from both a pharmacist and physician perspective. Respiratory Disease Franchise: A Focus on Prevention […]